Bristol-Myers Squibb Co. (BMY)
Bristol-Myers Squibb Co. is a global pharmaceutical company focused on discovering, developing, and delivering innovative medicines in areas such as oncology, immunology, cardiovascular, and neuroscience. Founded in 1858, it has a long history of advancing health through its diverse portfolio of prescription therapies.
Dividend History
Investors can expect a dividend payout of $0.62 per share, scheduled to be distributed in 44 days on November 3, 2025
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| November 3, 2025 | $0.62 | 2025-10-03 | 2025-10-03 |
| August 1, 2025 | $0.62 | 2025-07-03 | 2025-07-03 |
| May 1, 2025 | $0.62 | 2025-04-04 | 2025-04-04 |
| February 3, 2025 | $0.62 | 2025-01-03 | 2025-01-03 |
| November 1, 2024 | $0.60 | 2024-10-04 | 2024-10-04 |
Dividends Summary
- Bristol-Myers Squibb Co. has issued 88 dividend payments over the past 21 years
- The most recent dividend was paid 50 days ago, on August 1, 2025
- The highest dividend payed out to investors during this period was $0.62 per share
- The average dividend paid during this period was $0.39 per share.
Company News
The global cell therapy market is projected to grow from $5.88 billion in 2024 to $44.39 billion by 2034, driven by rising demand for regenerative medicine, advancements in biotechnology, and increasing prevalence of chronic diseases.
Over 25 therapies from 20+ pharmaceutical companies are currently in various clinical trial stages for bipolar disorder treatment, with promising new drug candidates targeting different neurological mechanisms.
Alexandria Real Estate, a healthcare-focused REIT, offers a 6.2% dividend yield and provides stable rental income from research properties across the healthcare sector, despite recent occupancy challenges.
Healthcare stocks have been stagnant since April, but offer attractive dividend yields ranging from 5.3% to 7.1%. The article highlights several healthcare REITs and pharmaceutical companies with high dividend potential despite market challenges.
The healthcare sector has gained momentum recently, with investors rushing to buy beaten-down stocks. The performance of major healthcare ETFs like XLV, VHT, IYH, and FHLC will depend on the upcoming earnings releases of big names like Pfizer, Merck, Amgen, AbbVie, Bristol Myers Squibb, and Eli Lilly.
